By Jaclyn Jaeger2018-02-12T12:15:00
Novartis has issued a response concerning ongoing corruption investigations by both Greek and U.S. authorities.
2019-07-19T15:19:00Z By Jaclyn Jaeger
Swiss pharmaceutical drug maker Novartis announced it has set aside $700 million for a potential settlement in a long-running lawsuit over allegations that the company paid hundreds of millions of dollars in kickbacks to doctors to induce them into prescribing drugs to patients to boost their sales.
2018-03-13T10:00:00Z By Jaclyn Jaeger
Ethics and compliance officers in the pharmaceutical industry can learn a lot from the troubles of Novartis, which faced a firestorm of criticism from shareholders at its last annual meeting.
2025-07-02T18:31:00Z By Aaron Nicodemus
Emerging enforcement priorities of the U.S. Department of Justice’s health care fraud division align with the Trump administration’s emphasis on prosecuting transnational criminal organizations and ending opioid trafficking.
Site powered by Webvision Cloud